Figure 4.

65 year old female with NSCLC. Initial CT scan shows large soft tissue mass in the RML (Figure  4A). After 3 cycles of Bevacizumab (Avastin) the mass demonstrates typical antiangiogenesis effect with peripheral and cavitation associated with mild overall decrease in the size of the mass (Figure  4B).